An additional dimension of this multifaceted relationship is the observation that plasma levels of vascular endothelial growth factor (VEGF) exhibit variation in patients with schizophrenia, particularly prior to antipsychotic treatment. This evidence concerns the gene VEGFA and schizophrenia.